Ustekinumab in Pediatric Crohn’s disease

Ustekinumab in Pediatric Crohn’s disease

In this multi-center study (@ChuSteJustine @HopitalChildren @BCCHF @HopRobertDebre), we found that children living with #crohnsdisease who failed at least 1 antiTNF, had at 12 months,

38.6% clinical remission 

47.8% clinical response

with #ustekinumab

#Jantchoulab

https://tinyurl.com/y7bju3yq

 

jantchou

%d